PDL192

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2011

2011

Abstract 1772: PDL192, a humanized anti-Tweak receptor monoclonal antibody, mediates antitumor effects in primary human breast carcinoma xenografts

L. D. PlaterA. Vincent‐Salomon D. Decaudin
2011
Corpus ID: 72834788

Background: PDL192 is a humanized IgG1 monoclonal antibody that binds the human TWEAK receptor (TweakR). TweakR, a member of the…